Cargando…
Association Study of Val66Met Polymorphism in Brain-Derived Neurotrophic Factor Gene with Clozapine-Induced Metabolic Syndrome: Preliminary Results
The prevalence of the metabolic syndrome (MetS) is higher among patients receiving atypical antipsychotics (AAPs) treatment, and even among AAPs, treatment with clozapine has been shown to be associated with a higher long-term incidence rate of MetS. Likewise, brain-derived neurotrophic factor (BDNF...
Autores principales: | Zhang, Yi, Chen, Meijuan, Wu, Zhiguo, Chen, Jun, Yu, Shunying, Fang, Yiru, Zhang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742721/ https://www.ncbi.nlm.nih.gov/pubmed/23967328 http://dx.doi.org/10.1371/journal.pone.0072652 |
Ejemplares similares
-
Association of Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism with Primary Dysmenorrhea
por: Lee, Lin-Chien, et al.
Publicado: (2014) -
Electrophysiological correlates of the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism
por: Roy, Nikita, et al.
Publicado: (2020) -
Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis
por: Wang, Zuowei, et al.
Publicado: (2014) -
Brain-derived neurotrophic factor (Val66Met) polymorphism and olfactory ability in young adults
por: Tonacci, Alessandro, et al.
Publicado: (2013) -
Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism Modulates Reversible Cerebral Vasoconstriction Syndromes
por: Chen, Shih-Pin, et al.
Publicado: (2011)